Medical Technology Analyst Zimmerman holds meetings with management in Minneapolis on December 9-10 hosted by BTIG.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PEN:
- Penumbra price target raised to $240 from $210 at Morgan Stanley
- Penumbra price target raised to $270 from $232 at BTIG
- Penumbra price target raised to $250 from $235 at Piper Sandler
- Penumbra’s CAVT technology shows benefits in pulmonary embolism
- Penumbra price target raised to $232 from $222 at RBC Capital